Trending Topic

Digital illustration of human lungs with glowing connections and structures.
8 mins

Trending Topic

Developed by Touch
Mark CompleteCompleted
BookmarkBookmarked

A 68-year-old woman with nodular bronchiectasis presents with persistent productive cough, intermittent regurgitation and recurrent ‘chest infections’ despite 12 months of once-daily proton pump inhibitor (PPI) therapy. Her clinician has doubled the PPI dose and is considering long-term azithromycin. Sputum has not been sent for mycobacterial culture in over a year. She has lost 3 kg, at times […]

Free CME Accredited Learning

Our accredited content is designed to impact patient health outcomes, by ensuring that it provides you with a learning experience that will positively impact your clinical practice, based on adult learning preferences and intuitive instructional design. All activities are developed in collaboration with leading faculty and education partners.

touchRESPIRATORY

Speciality Filter

Select Specialty or Clinical Area

Clear All
Update Filters
Close Popup
37 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchEXPERT FOCUS
Prof. Marina Garassino, Prof. Jakob Nikolas Kather, Prof. Fernando Lopez-Rios

Three experts discuss how computational pathology can enhance diagnosis and treatment in NSCLC.

37 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchPANEL DISCUSSION
Dr Lyudmila Bazhenova, Dr Elvire Pons-Tostivint, Dr Julia Rotow

Expert faculty discuss antibody–drug conjugates (ADCs) in NSCLC with brain metastases, reviewing the clinical trial evidence, practical patient selection and sequencing alongside local CNS therapies, and the emerging pipeline of investigational ADCs.

32 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked

Case-based expert insights on diagnosis, monitoring and individualized management in LOPD.

93 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchCLINICAL PERSPECTIVES
Prof. Pasi Jänne, Prof. Nicholas Girard, Dr Helena Yu, Prof. Paul Hofman

This three-part series covers managing advanced NSCLC after EGFR-TKI therapy, highlighting new treatments, biomarkers and MDT-based care.

37 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchCASES
Dr Athénaïs Boucly, Prof. Pilar Escribano Subìas

Expert case discussions on PAH focusing on diagnosis, risk assessment and treatment strategies.

15 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked

Expert insights on the practical application of immunotherapy in early-stage NSCLC

13 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchEXPERT FOCUS
Dr Christine Bestvina

Watch an expert discuss the key clinical questions surrounding currently approved RET inhibitors in NSCLC.

54 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchSYMPOSIUM
Prof. Marina Garassino, Prof. Jaruskha Naidoo, Prof. David Planchard

In this symposium, three lung cancer specialists share their insights on TROP2-targeted ADCs in NSCLC

64 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchCONGRESS
Prof. Tahseen Mozaffar, Dr Jennifer L Cohen, Prof. Benedikt Schoser

Leading experts in Pompe disease explore key data from WMS 2024 and WORLDSymposium 2025.

20 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked

Watch a lung cancer expert discuss the latest data for ADCs in NSCLC and their implications for clinical practice.

99 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchCLINICAL PERSPECTIVES
Dr Helena Yu, Dr Antonio Passaro, Dr Aaron Lisberg, Dr Sara Pilotto, Ms Jackie Fenemore, Prof. Egbert Smit

Experts provide insights on tailoring treatment in patients with EGFR-mutant and wildtype NSCLC.

39 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchMDT
Dr Lizza Hendriks, Dr Jacob Sands, Prof. Suresh Senan

A multidisciplinary team discusses the role of immune checkpoint inhibitors (ICIs) in limited-stage small cell lung cancer (LS-SCLC).

55 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchMDT
Dr Xiuning Le, Dr Christine Argento, Dr Sandra Cuellar, Ms Stephanie McDonald, Prof. Albrecht Stenzinger

A multidisciplinary team of specialists discuss the use of targeted therapies for NSCLC with MET alterations.

34 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchIN CONVERSATION
Prof. Jean-Luc Vachiéry, Prof. Manreet Kanwar

Watch two experts discuss the diagnosis, risk stratification and treatment of pulmonary arterial hypertension.

41 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchPANEL DISCUSSION
Dr Razelle Kurzrock, Dr Lyudmila Bazhenova, Dr Ignacio Wistuba

Two oncologists and a pathologist discuss the implications of HER2 targeting in solid tumours, with a focus on NSCLC.

37 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchIN CONVERSATION
Prof. Enriqueta Felip, Prof. Keith Kerr

An oncologist and a pathologist discuss HER2 testing and treatments for HER2-altered NSCLC.

33 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked

Prof. Wakelee discusses the latest evidence on immunotherapy for early-stage, resectable NSCLC.

31 mins
CE/CME accredited
Mark CompleteCompleted
BookmarkBookmarked
touchEXPERT OPINIONS
Dr Michael Perch, Dr Howard J Huang, Dr Aldo Iacono

Three experts discuss the pathogenesis, diagnosis and treatment for bronchiolitis obliterans syndrome (BOS).

Load More...

Society & Congress Partners

touchRESPIRATORY is proud to partner with leading medical societies and congresses from around the world to bring you news and insight from virtual and live events

View All

All touchIME CME activities are accredited. Learners can claim ACCME, ANCC, ACPE or EBAC credits upon completion of the activities. This content is for healthcare professionals only.

Close Popup